REATA PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Reata Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2022.
  • Reata Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was $193M.
  • Reata Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$87.6M, a 71.2% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$312M, a 4.88% decline from 2021.
  • Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$297M, a 20% decline from 2020.
  • Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$248M, a 14.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$312M -$14.5M -4.88% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 -$297M -$49.6M -20% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 -$248M +$42.4M +14.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 -$290M -$210M -260% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$80.5M -$32.9M -69% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$47.7M -$41.4M -666% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 -$6.23M -$4.78M -329% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$1.45M -$2.14M -310% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 $689K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.